HealthStream (HSTM) Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HealthStream in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" HSTM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSTM, but not buy additional shares or sell existing shares.
View HSTM analyst ratings or view top-rated stocks.

1 analysts have issued twelve-month price targets for HealthStream's stock. Their HSTM share price forecasts range from $23.00 to $26.00. On average, they predict the company's stock price to reach $24.50 in the next year. This suggests a possible upside of 1.7% from the stock's current price.
View analysts price targets for HSTM or view top-rated stocks among Wall Street analysts.

HealthStream's stock was trading at $24.84 at the beginning of the year. Since then, HSTM shares have decreased by 3.0% and is now trading at $24.10.
View the best growth stocks for 2023 here.

HealthStream saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 438,000 shares, a decline of 11.3% from the April 30th total of 494,000 shares. Based on an average daily trading volume, of 130,500 shares, the days-to-cover ratio is presently 3.4 days. Approximately 1.8% of the company's stock are sold short.
View HealthStream's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, July 24th 2023.
View our HSTM earnings forecast.

HealthStream, Inc. (NASDAQ:HSTM) posted its quarterly earnings results on Monday, April, 24th. The technology company reported $0.12 EPS for the quarter, topping the consensus estimate of $0.07 by $0.05. The technology company had revenue of $68.90 million for the quarter, compared to the consensus estimate of $68.26 million. HealthStream had a net margin of 4.37% and a trailing twelve-month return on equity of 3.17%. The company's quarterly revenue was up 5.4% compared to the same quarter last year. During the same period last year, the business posted $0.09 EPS.

HealthStream declared a quarterly dividend on Monday, April 24th. Shareholders of record on Monday, June 12th will be paid a dividend of $0.025 per share on Friday, June 23rd. This represents a $0.10 annualized dividend and a yield of 0.41%. The ex-dividend date is Friday, June 9th.
Read our dividend analysis for HSTM.

ETFs with the largest weight of HealthStream (NASDAQ:HSTM) stock in their portfolio include Fidelity Digital Health ETF (FDHT), Global X Cloud Computing ETF (CLOU), Inspire Fidelis Multi Factor ETF (FDLS), Invesco S&P SmallCap Low Volatility ETF (XSLV), Vanguard U.S. Minimum Volatility ETF (VFMV), Invesco S&P SmallCap Health Care ETF (PSCH), ETC 6 Meridian Low Beta Equity Strategy ETF (SIXL) and First Trust Multi-Manager Small Cap Opportunities ETF (MMSC).

HealthStream (NASDAQ:HSTM) pays an annual dividend of $0.10 per share and currently has a dividend yield of 0.43%. The dividend payout ratio is 25.64%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HSTM will have a dividend payout ratio of 22.73% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HSTM.

HealthStream issued an update on its FY 2023 earnings guidance on Thursday, April, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $277.50 million-$283.00 million, compared to the consensus revenue estimate of $280.64 million.

107 employees have rated HealthStream Chief Executive Officer Robert A. Frist Jr. on Glassdoor.com. Robert A. Frist Jr. has an approval rating of 78% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthStream investors own include Gilead Sciences (GILD), Netflix (NFLX), Johnson & Johnson (JNJ), AbbVie (ABBV), Pfizer (PFE), Tesla (TSLA), Enterprise Products Partners (EPD), Amgen (AMGN), Activision Blizzard (ATVI) and Boeing (BA).

HealthStream trades on the NASDAQ under the ticker symbol "HSTM."

HealthStream's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (13.65%), Dimensional Fund Advisors LP (4.99%), Acadian Asset Management LLC (3.10%), State Street Corp (3.02%), Punch & Associates Investment Management Inc. (2.55%) and Renaissance Technologies LLC (1.91%). Insiders that own company stock include Frank Gordon, J Edward Pearson, Jeffrey L Mclaren, Robert A Frist Jr and Tate Deborah Taylor.
View institutional ownership trends.

Shares of HSTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HSTM stock can currently be purchased for approximately $24.10.

HealthStream (NASDAQ:HSTM) has a market capitalization of $739.39 million and generates $266.83 million in revenue each year. The technology company earns $12.09 million in net income (profit) each year or $0.39 on an earnings per share basis.

The company employs 1,154 workers across the globe.

HealthStream's mailing address is 500 11TH AVENUE NORTH SUITE 1000, NASHVILLE TN, 37203. The official website for the company is www.healthstream.com. The technology company can be reached via phone at (615) 301-3100, via email at mollie.condra@healthstream.com, or via fax at 615-301-3200.